LOUISVILLE, Ky. — Humana Inc., one of the nation’s leading health and well-being companies, has named Dr. Vishal Agrawal to the position of chief strategy and corporate development officer. Humana also announced that it is realigning its Care Delivery Organization under the leadership of Chief Financial Officer Brian Kane.
In the role of chief strategy and corporate development officer, Agrawal will report directly to Humana President and CEO Bruce Broussard, and will serve as a member of Humana’s Management Team. Agrawal will be responsible for advancing the company’s strategic insights and planning process, establishing direction for merger, acquisition and joint venture activities, while maximizing capabilities to create competitive advantage. He will assume the role effective Dec. 10, 2018.
Agrawal brings more than 20 years of experience in planning and implementing strategies to drive growth and performance improvement across publicly traded and privately held health care organizations. He comes to Humana from The Carlyle Group, a Washington, D.C.-based financial services and investment firm, where he served as senior advisor. Previously, Agrawal oversaw strategy for Ciox Health, a health care information management company, as president and chief growth officer. Agrawal has also served as president of Harris Healthcare Solutions and partner at McKinsey and Company.
“As a physician and a highly strategic health care business leader, Vishal’s expertise spans multiple domains,” said Broussard. “His unique perspective will help Humana continue to advance its integrated care delivery market strategy, which revolves around the health plan member, with a particular focus on seniors living with chronic conditions.”
Agrawal is a graduate of the Yale University School of Medicine. He also holds a master’s degree in molecular biophysics and a bachelor’s degree in molecular biophysics and biochemistry, both also from Yale.
Agrawal succeeds Christopher Hunter, who recently assumed leadership responsibility for the company’s Group, Specialty and Military lines of business. Hunter, who joined the company in 2014, has played an instrumental role in advancing the company’s strategy, particularly as the company emerged as a stand-alone entity after the termination of the Aetna transaction. Chris succeeds Beth Bierbower in this role, who as previously announced, is leading the company’s efforts to develop a new senior health care experience in the company’s recently created Humana Studio H in Boston. Both Hunter and Bierbower are members of the Management Team reporting to Broussard.
In addition, Humana’s Care Delivery Organization will now become part of the company’s Finance organization, under the leadership of Chief Financial Officer Brian Kane. An important part of Humana’s integrated care delivery strategy involves expanding clinical capabilities with a commitment to providing care delivery solutions to serve the members of many different payors.
“Our desire to grow payor-agnostic care delivery through acquisitions and de novo centers will be further realized by realigning the entity to the Finance organization,” said Broussard. “There, the Care Delivery Organization can leverage the operational and financial expertise of Brian Kane and his leadership team to advance its primary care capabilities.”
Reporting to Kane will be Renee Buckingham, president of Humana’s Care Delivery Organization. In a short period of time, Renee and her team have helped facilitate the reorganization of existing Florida and Texas care delivery assets into Conviva, consummated the acquisition and subsequent integration of central Florida’s Family Physicians Group, and driven the growth of Partners in Primary Care (PIPC) by entering new markets with PIPC centers, broadening the relationship with several of the company’s joint venture partners and establishing a strategic partnership with Walgreens to co-locate senior-focused PIPC centers in certain Kansas City-area stores.